An Epidemic? Tommy John Surgery for 15 MLB Pitchers in 2014

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn
Ivan Nova via Keith Allison Flickr

Source: Keith Allison / Flickr

When Dr. James Andrews performed Tommy John surgery on the Padres’ Josh Johnson April 24, it marked the fourteenth time a Major League Baseball pitcher went under the knife for the procedure in 2014. Andrews will return to the operating room April 29 to repair the ulnar collateral ligament (UCL) tear in the right arm of the Yankees’ Ivan Nova. That makes fifteen pitchers before the first month of the 2014 season has ended. At this point, Andrews’ estimation that there is an ‘epidemic’ in baseball seems to be an understatement.

Even before Nova, Johnson, and one other pitcher were added to the list of twelve, Dr. Andrews spoke about the disturbing number of UCL injuries on the MLB Network Radio show on Sirius XM.

“I think it’s a trend,” Andrews said. “I’m inundated [in the winter months] with Tommy John injuries.” Andrews’s name seems to pop up in the news or on baseball shows every other day, which is why he has called the trend “an epidemic.” The majority of injuries he’s seeing are freshmen in college and even younger, in contrast to his previous experience when it was only professionals needing the surgery.

However, the MLB pitchers having Tommy John surgery in 2014 could make up an All-Star team: Matt Moore, Kris Medlen, Jarrod Parker, Patrick Corbin, and Brandon Beachy are just a few of the high profile players on the list. Even more disturbing is how many pitchers have undergone their second Tommy John surgery before the age of 30. Parker, Medlen, and Johnson are among those who’ve had the procedure twice in their young careers. Tommy John himself recently weighed in on “unreal” rash of injuries in 2014.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business